dpp 4 inhibitor glp 1 agonist Specific actions of GLP-1 receptor agonists and DPP4 inhibitors for the treatment of pancreatic β-cell impairments in type 2 diabetes Glucagon-like peptide-1 - Wikipedia

OX, oxytocin

From Diabetes to Oncology: Glucagon-like Peptide-1 (GLP-1) Receptor Agonists Dual Role in Prostate Cancer. Cancers, 16*(1538)

Think of Zepbound as using two complementary approaches simultaneously rather than relying on one very effective approach

B., NFkappaB and Cancer: How Intimate Is This Relationship, Molecular and Cellular Biochemistry 336 (2010): 2537

Longer life expectancy with less risk of premature death from heart disease, stroke, diabetes, and other obesity-related conditions

Clinical Trials Demonstrating Reductions in Body Weight with GLP-1RAs Several clinical trials have reported that the effects described above resulted in larger reductions in body weight with GLP-1RA therapy compared with placebo in participants with obesity